← Leaderboards
Jie Xu
Wayne State University
$7,149,926
Attributed
$13,175,410
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,175,410 · 15
By mechanism
R01$9,659,905 · 4
R21$1,698,465 · 4
R41$618,460 · 3
R44$579,047 · 1
R42$306,779 · 1
R43$175,144 · 1
Top collaborators
- Sidhartha Tan8 shared
- Jeannette M Vasquez Vivar8 shared
- Jian-Ping Jin3 shared
- Kezhong Zhang3 shared
- Moses Turkle Bility2 shared
- Fei Sun2 shared
- Jessica Reed1 shared
Most similar at Wayne State University
Same institution · by research overlap
- Sidhartha Tan$11,899,699
- Jeannette M Vasquez Vivar$5,991,870
Others in their field
Top investigators on “Oryctolagus Cuniculus”
- Jaap Goudsmit · Beth Israel Deaconess Medical Center$44,131,193
- John P Moore · Weill Medical College Of Cornell Univ$37,533,312
- Peter Scott Heeger · Case Western Reserve University$27,118,531
- Dafna Bar-Sagi · State University New York Stony Brook$19,610,586
- Michael G Agadjanyan · Institute For Molecular Medicine$18,913,438
- Michael Welch · Washington University$18,835,712
Research focus
Oryctolagus CuniculusAnimal ModelFamily SuidaeAnimalsKnock-OutPhenotypeGenesMutationKnock-InTissuesPathway InteractionsCellsHuman DiseaseMolecularBreedingTransgenic OrganismsInsightBirthLifeCrispr/Cas TechnologyPathogenesisGenomePatternNonhuman Primate
Grant awards (32)
Targeting SGLTs for liver disease in a rabbit model of cystic fibrosis$633,678
R01 · FY2025 · DK · contact PI
Ferroptosis in knock-in sepiapterin reductase mutation rabbits$595,814
R01 · FY2025 · NS
Probing Role of Tetrahydrobiopterin in Cerebral Palsy by Using Transgenic Rabbits$564,648
R01 · FY2025 · NS
Probing Role of Tetrahydrobiopterin in Cerebral Palsy by Using Transgenic Rabbits$612,103
R01 · FY2024 · NS
Targeting SGLTs for liver disease in a rabbit model of cystic fibrosis$610,883
R01 · FY2024 · DK · contact PI
Ferroptosis in knock-in sepiapterin reductase mutation rabbits$580,836
R01 · FY2024 · NS
Novel Selective SGLT-1 Inhibitors for Adjunctive Therapy for Cystic Fibrosis Associated Metabolic Diseases$306,779
R42 · FY2024 · DK · contact PI
Targeting SGLTs for liver disease in a rabbit model of cystic fibrosis$659,654
R01 · FY2023 · DK · contact PI
Probing Role of Tetrahydrobiopterin in Cerebral Palsy by Using Transgenic Rabbits$634,263
R01 · FY2023 · NS
Ferroptosis in knock-in sepiapterin reductase mutation rabbits$605,476
R01 · FY2023 · NS
Probing Role of Tetrahydrobiopterin in Cerebral Palsy by Using Transgenic Rabbits$637,429
R01 · FY2022 · NS
Development of miCas9 mediated gene editing therapies for cystic fibrosis$246,100
R41 · FY2022 · HL · contact PI
Probing Role of Tetrahydrobiopterin in Cerebral Palsy by Using Transgenic Rabbits$667,532
R01 · FY2021 · NS
Rabbit model for cystic fibrosis$669,737
R01 · FY2019 · HL
Engraftment of human hematopoietic stem cells to immunodeficient rabbits$243,584
R21 · FY2019 · OD · contact PI
Rabbit model for cystic fibrosis$165,851
R01 · FY2019 · HL
Rabbit model for cystic fibrosis$669,737
R01 · FY2018 · HL
Development of an aging rabbit model for the study of atherosclerosis$232,500
R21 · FY2018 · AG · contact PI
Development of conditional and inducible gene targeting tools in rabbits$221,944
R21 · FY2018 · OD · contact PI
Engraftment of human hematopoietic stem cells to immunodeficient rabbits$207,999
R21 · FY2018 · OD · contact PI
Rabbit model for cystic fibrosis$669,737
R01 · FY2017 · HL
A novel rabbit model of cystic fibrosis$220,875
R21 · FY2017 · OD · contact PI
Development of an aging rabbit model for the study of atherosclerosis$193,750
R21 · FY2017 · AG · contact PI
Development of conditional and inducible gene targeting tools in rabbits$184,063
R21 · FY2017 · OD · contact PI
Rabbit model for cystic fibrosis$682,527
R01 · FY2016 · HL
A novel rabbit model of cystic fibrosis$193,750
R21 · FY2016 · OD · contact PI
development of immunodeficient rabbit models$186,180
R41 · FY2016 · AI · contact PI
Modernize animal pharming with emerging gene targeting technologies$186,180
R41 · FY2014 · GM · contact PI
Derivation of germline competent rabbit embryonic stem cell lines$579,047
R44 · FY2010 · RR · contact PI
Restoration dynamics of Xp chromosomes in cloned bovine embryos$68,110
R03 · FY2008 · HD · contact PI
Derivation of Germline Competent Rabbit Embryonic Stem Cell Lines$175,144
R43 · FY2007 · RR · contact PI
Restoration dynamics of Xp chromosomes in cloned bovine embryos$69,500
R03 · FY2007 · HD · contact PI